| ICD-10 from 2011 - 2016 ICD Code C50.42 is a non-billable code. To code a diagnosis of this type, you must use one of the three child codes of C50.42 that describes the diagnosis 'malignant neoplasm of upper-outer quadrant of breast, male' in more detail.
Full Answer
C50.112 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM C50.112 became effective on October 1, 2018. This is the American ICD-10-CM version of C50.112 - other international versions of ICD-10 C50.112 may differ. C50.112 is applicable to female patients.
C50.012 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C50.012 became effective on October 1, 2021. This is the American ICD-10-CM version of C50.012 - other international versions of ICD-10 C50.012 may differ.
C50.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. The 2022 edition of ICD-10-CM C50.0 became effective on October 1, 2021.
C50.112 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
A form of breast cancer in which the tumor grows from ducts beneath the nipple onto the surface of the nipple. Symptoms commonly include itching and burning and an eczema-like condition around the nipple, sometimes accompanied by oozing or bleeding.
C50 Malignant neoplasm of breast.
C61 Malignant neoplasm of prostate.
Invasive ductal carcinoma is cancer (carcinoma) that happens when abnormal cells growing in the lining of the milk ducts change and invade breast tissue beyond the walls of the duct. Once that happens, the cancer cells can spread.
919 Malignant neoplasm of unspecified site of unspecified female breast.
A malignant neoplasm (NEE-oh-plaz-um) is another term for a cancerous tumor. The term “neoplasm” refers to an abnormal growth of tissue. The term “malignant” means the tumor is cancerous and is likely to spread (metastasize) beyond its point of origin.
ICD-10 code Z85. 46 for Personal history of malignant neoplasm of prostate is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Prostate cancer is assigned to ICD-9-CM diagnosis code 185. Carcinoma in situ of the prostate is classified to code 233.4, and a benign neoplasm of the prostate goes to code 222.2.
Assign a code for all metastatic and primary sites documented by the physician. Only assign code C80. 0, Disseminated malignant neoplasm, unspecified, if the patient has advanced metastatic disease and the primary or secondary sites are not specified. Assign code C80.
What's the difference between invasive ductal carcinoma and ductal carcinoma in situ? Ductal carcinoma in situ (DCIS) means that the cancer cells are still contained in your milk ducts. Invasive ductal carcinoma (IDC) means that the cancer has begun to spread to (or invade) your surrounding breast tissue.
Generally, the stage of invasive ductal carcinoma is described as a number on a scale of I through IV. Stages I, II, and III describe early-stage cancers, and stage IV describes cancers that have spread outside the breast to other parts of the body, such as the bones or liver.
Once the cancer has metastasized to distant organs like the bones or liver, the five-year survival rate drops by almost three fourths. Invasive ductal carcinoma (also called infiltrating ductal carcinoma) is the most common type of breast cancer, accounting for about 80% of all cases of breast cancer.
Malignant neoplasm of upper-outer quadrant of breast, male 1 C50.42 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 The 2021 edition of ICD-10-CM C50.42 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of C50.42 - other international versions of ICD-10 C50.42 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.